Invasive Group Streptococcal Disease
📧 Sign up to get email alerts when something new happens for Invasive Group Streptococcal Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-26Clinical Trial Update: Comprehensive Outcomes Monitoring for Peri- and Postnatal Invasive Group B Strep Sequelae (COMPPASS) Registry
The COMPPASS registry study by Precia Group aims to comprehensively monitor outcomes for peri- and postnatal invasive Group B Streptococcus …
-
CLINICAL_TRIALS research · 2018-05-18Clinical Trial Update: Genetic Susceptibility to Severe Streptococcal Infections
The update describes a University of Oxford clinical trial exploring genetic factors that influence susceptibility to severe invasive strept…
-
CLINICAL_TRIALS research · 2016-06-24Clinical Trial Update: Burden of Invasive Group B Streptococcal Disease in Infants and Resistance Surveillance in China
This clinical trial update reports on the burden of invasive Group B Streptococcal disease in infants and monitoring of antibiotic resistanc…
-
CLINICAL_TRIALS research · 2015-01-07Clinical Trial Update: Burden of Invasive Group B Streptococcal (GBS) Disease in Young Infants in China
A completed clinical trial update assessing the burden of invasive Group B streptococcal disease in young infants in China.
-
CLINICAL_TRIALS trial_result · 2011-12-08Clinical Trial Update: A Phase I, Randomized, Single-blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity of a Dose Range of a Monovalent Glycoconjugate Antigen Vaccine of Group B Streptococcus in Healthy Women 18-40 Years of Age [Phase 1]
Phase I randomized, single-blind trial evaluating the safety and immunogenicity of dose-ranging monovalent glycoconjugate vaccine targeting …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.